Answers are grounded in this paper and cite their sources.
Cohort study identifies prognostic factors and relapse patterns in diffuse hemispheric glioma, suggesting the need for improved therapies.
This cohort highlights prognostic factors for patients with DHG, H3 G34, describes relapse patterns, and therapy approaches. Clinical trials and prospective registries are needed to improve outcomes.
No takes yet. Share an insight, caveat, or question.
Crowell et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: